|
시장보고서
상품코드
2143397
CircRNA 합성 시장 : 제품 유형별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)CircRNA Synthesis Market, By Product Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
CircRNA 합성 시장 규모는 2025년에 2억 1,070만 달러로 평가되며, 2026년부터 2033년까지 CAGR 16.2%로 확대될 것으로 전망됩니다.
CircRNA 합성에는 연구 개발 및 치료법 개발을 위한 공유 결합으로 닫힌 RNA의 제조에 기여하는 설계, 체외 전사, 고리화, 정제 및 품질 관리 과정이 포함됩니다. 기존의 선형 RNA 제조와 달리, 이 워크플로우에서는 고리화 효율 관리 외에도, 미고리화 RNA, 이중가닥 RNA, 절단 산물 및 기타 면역원성 불순물의 제거도 관리해야 합니다. 따라서 이 시장에는 단백질 발현, 신약 개발, 백신, 유전자 치료, 바이오마커 연구를 지원하기 위한 합성 장비 및 시약은 물론, 전문적인 위탁 제조 서비스도 포함됩니다. 2025년 'Advanced Science' 저널의 연구에 따르면, 효소와 셀룰로오스를 결합한 통합 정제 전략을 통해 CircRNA 제조 수율을 10배 이상 향상시키는 동시에 면역 활성화를 저감할 수 있음이 입증되었습니다. 이러한 연구 결과를 바탕으로, 구매 우선순위는 단순한 RNA 생성뿐만 아니라 재현성 있는 고리화, 순도, 분석적 검증 및 확장 가능한 워크플로로 이동하고 있습니다.
CircRNA 합성 시장 - 시장 역학
고순도 및 확장성이 뛰어난 순환화 워크플로우에 대한 수요
제조 과정에서 주요 과제는 CircRNA를 실험실 단계에서 까다로운 중개 연구에 사용 가능한 소재로 전환하는 것입니다. 기존의 리게이션법이나 리보자임법에서는 서열, 길이, 정제 및 제품별 측면에서 제약이 발생할 수 있으므로, 공정 제어가 차별화 요소가 됩니다. 2025년 'Nature Communications'지에 게재된 연구에 따르면, 화학적 고리화는 35-4,000 뉴클레오티드 길이의 RNA에 유효하며, 고리화 효율은 최대 60%에 달하는 것으로 나타났으며, 이는 합성 연구를 통해 설계의 폭이 넓어지고 있음을 보여줍니다. 한편, 연구자들은 스카(scar)가 없는 설계와 불순물의 보다 효과적인 제거를 계속해서 중시하고 있습니다. 궁극적인 목표는 CircRNA의 생산량을 늘리는 것이 아닙니다. 공급업체는 이제 제어 가능한 고리화, 유연한 서열, 정제 및 특성 평가를 단일 통합 생산 워크플로우로 제공해야 합니다. 공정 제어는 전체 공정 전반에 걸쳐 유지되어야 합니다. 공급업체는 공정 제어를 핵심 중점 사항으로 계속해서 자리매김해야 합니다.
CircRNA 합성 시장 - 시장 세분화 분석:
세계 CircRNA 합성 시장은 제품 유형, 용도, 최종사용자 및 지역을 기준으로 세분화되어 있습니다.
제품 유형별 세분화를 살펴보면, 각 연구소가 내부 프로세스 관리와 기술적 전문 지식을 어떻게 조화시키고 있는지 알 수 있습니다. 조직이 전사, 정제, 크로마토그래피 및 분석 워크플로우를 필요로 하는 경우, 장비 선택이 중요해집니다. 시약이나 키트를 활용하면 전체 플랫폼을 구축하지 않고도 효소, 전사 성분, 라이게이션 시스템 및 정제용 시약을 이용할 수 있습니다. 서비스는 염기서열 설계, 고리화, 정제, 품질 관리를 전문 업체에 위탁한다는 점에서 독자적인 위치를 차지하고 있습니다. 예를 들어, GenScript사는 스카리스 PIE 및 스카리스 T4 라이게이션을 포함한 3가지 맞춤형 기법을 제공하며, 이는 코딩 영역과 비코딩 영역의 용도를 모두 아우릅니다. 상업적인 차이는 워크플로우의 소유권이 누구에게 있는지에 따라 발생합니다. 선진 연구 그룹은 프로세스를 구축할 수 있지만, 치료제 개발 기업들은 통합된 생산 및 특성 평가를 점점 더 선호하는 경향을 보이고 있습니다.
용도별로 보면 CircRNA가 생물학 분야에서 신약 개발 분야로 전환될 때 그 요구 사항은 크게 변화합니다. 신약 개발 분야에서는 CircRNA를 이용하여 단백질 발현, RNA 기능, 표적의 생물학적 특성 및 가능한 작용기전을 연구합니다. 이로 인해 서열 설계 및 신속한 변경에 대한 수요가 발생합니다. 한편, 신약 개발에서는 제조의 세부 사항이 다운스트림 결과에 영향을 미칠 가능성이 있으므로, 순도, 재현성, 생체 내 전환 성능, 면역원성 및 약물전달 시스템과의 적합성이 중시됩니다. ClinicalTrials.gov에는 순환 RNA 유래 종양 항원 백신을 이용한 제I/II상 임상시험이 게재되어 있으며, 환자 60명을 대상으로 2025년 12월 시작될 예정입니다. 이러한 움직임으로 인해 치료제 개발 분야에서 제조상의 수요가 발생하고 있습니다. CircRNA 공급업체는 RNA 생산을 독립적인 실험 공정으로 취급하기보다는, 합성의 품질과 용도에 특화된 생물학적 검증을 연계해야 합니다.
CircRNA 합성 시장 - 지역별 인사이트
아시아태평양에서는 CircRNA를 둘러싼 강력한 중개 연구 생태계가 구축되어 있으며, 중국에서는 학술 연구, 생명공학 발전, 규제 감독이 하나로 통합되어 있습니다. 2025년 1월, 상하이의 CirCode Biomed사는 자사의 CircRNA 치료제 ‘HM2002’가 중국 국가약품감독관리국(NMPA)으로부터 임상시험용 의약품(IND) 승인을 획득했다고 발표했습니다. 이 회사는 이를 중국에서 동종 승인을 받은 최초의 CircRNA 치료제라고 설명하고 있습니다. 이 획기적인 사건의 영향은 HM2002 치료제 그 자체를 넘어섭니다. 이는 제조, 불순물에 대한 엄격한 관리, 상세한 분석적 특성 평가, 그리고 확장 가능한 순환화 기술에 대한 수요가 증가하고 있음을 시사합니다. 중국은 2025년 ‘흉터 없는 순환화’ 및 ‘자가 스플라이싱 시스템’에 관한 연구를 포함하여 합성 연구를 지속적으로 추진하고 있습니다. 이 지역은 단순히 CircRNA 연구의 수혜자에 그치지 않고, 중개 연구에 대한 야망과 혁신이라는 두 가지 측면을 통해 이 기술을 적극적으로 형성해 나가고 있습니다. 개발과 과학의 시너지 효과로 인해 아시아태평양은 이 분야의 주요 원동력이 되고 있습니다.
북미의 CircRNA 참여는 RNA 기술 제공업체, 치료제 개발 기업, 그리고 미국의 규제 절차 간의 상호작용에 크게 영향을 받고 있습니다. 2025년 5월 30일, CirCode사는 HM2002가 심장 질환에 대해 FDA의 IND 승인을 획득했다고 발표했으며, 이로써 이 치료법의 규제적 여정이 중국 이외의 지역으로 확대되었습니다. 또 다른 움직임으로, FDA의 희귀질환용 의약품 지정 데이터베이스에 따르면, 간세포 증식 인자를 발현하는 순환 RNA 치료제가 2025년 10월 23일 폐색성 혈전성 혈관염에 대해 희귀질환용 의약품 지정을 받았습니다. 이러한 규제상의 진전은 치료용 등급의 품질을 갖춘 합성 및 엄격한 문서화의 필요성을 부각시키고 있습니다. 중요한 분야로는 동일성 검증, 순도 평가, 일관된 생산, 그리고 견고한 제조 관리가 있습니다. CircRNA를 실험실 규모의 연구에서 본격적인 치료 프로그램으로 발전시키는 데 있어 북미는 중심적인 역할을 하고 있습니다. 시장은 공식적인 생산 기준과 엄격한 분석 기법으로 전환되고 있으며, 이는 연구용 등급의 CircRNA에서 개발 준비가 완료된 CircRNA로의 전환을 의미합니다.
목차
제1장 CircRNA 합성 시장 개요
제2장 주요 요약
제3장 CircRNA 합성 주요 시장 동향
제4장 CircRNA 합성 산업 분석
제5장 CircRNA 합성 시장 : 높아지는 지정학적 긴장의 영향
제6장 CircRNA 합성 시장 구도
제7장 CircRNA 합성 시장 : 제품 유형별
제8장 CircRNA 합성 시장 : 용도별
제9장 CircRNA 합성 시장 : 최종사용자별
제10장 CircRNA 합성 시장 : 지역별
제11장 주요 벤더 분석 : CircRNA 합성 산업
제12장 AnalystView의 전방위 전망
KSM 26.10.14CircRNA Synthesis Market size was valued at US$ 210.7 Million in 2025, expanding at a CAGR of 16.2% from 2026 to 2033.
CircRNA synthesis encompasses the design, in vitro transcription, circularization, purification, and quality control processes that contribute to the production of covalently closed RNA for research and therapeutic development. Unlike traditional linear RNA production, the workflow must control both the efficiency of circularization and the removal of uncircularized RNA, double-stranded RNA, truncated products, and other immunogenic impurities. Hence, the market also comprises synthesis instruments and reagents along with specialized custom production services to support protein expression, drug discovery, vaccines, gene therapy, and biomarker research. An integrated enzymatic and cellulose-based purification strategy has been demonstrated in a 2025 Advanced Science study to increase the yield of CircRNA manufacturing by more than 10-fold, as well as to reduce immune activation. This evidence shifts buying priorities to reproducible circularization, purity, analytical validation, and scalable workflows rather than just RNA generation.
CircRNA Synthesis Market- Market Dynamics
Demand for Higher Purity and More Scalable Circularization Workflows
The main manufacturing challenge is moving CircRNA from laboratory experiments to material that can be used in demanding translational studies. Traditional ligation and ribozyme methods can create limits on sequence, length, purification, and by-products, so process control becomes a differentiator. A 2025 Nature Communications study showed that chemical circularization works for RNA lengths from 35 to 4,000 nucleotides and that circularization efficiency can reach up to 60 percent, showing that synthesis research is expanding the design space. Meanwhile, researchers continue to stress scar-free designs and better impurity removal. The final requirement is not more CircRNA output; suppliers must now offer controllable circularization, flexible sequences, purification, and characterization as a single integrated production workflow. Process control must be maintained throughout. Suppliers must keep process control as a core focus.
CircRNA Synthesis Market- Segmentation Analysis:
The Global CircRNA Synthesis Market is segmented on the basis of Product Type, Application, End User, and Region.
By product type, product type segmentation shows how laboratories balance internal process control with technical expertise. Instruments matter when organizations need transcription, purification, chromatography, and analytical workflows. Reagents and kits provide access to enzymes, transcription components, ligation systems, and purification chemistry without building a whole platform. Services occupy a unique position because they transfer sequence design, circularization, purification, and quality control to specialist providers. GenScript, for example, offers three custom methods-PIE with a scarless PIE and scarless T4-ligation-covering both coding and non-coding uses. The commercial difference comes from who owns the workflow: advanced research groups can build processes while therapeutic developers increasingly prefer integrated production and characterization.
By application, application needs shift significantly when CircRNA moves from biology to therapeutic work. Drug discovery uses CircRNA to study protein expression, RNA function, target biology, and possible mechanisms. This creates a demand for sequence designs and rapid changes. Therapeutics development emphasizes purity, reproducibility, translation performance, immunogenicity, and delivery compatibility because manufacturing details can change downstream results. ClinicalTrials.gov listed a Phase I/II study using a circular RNA-derived tumor-antigen vaccine with 60 patients, with a planned start in December 2025. This move creates a manufacturing need in therapeutics development: CircRNA suppliers must link synthesis quality with application-specific biological checks instead of treating RNA production as a separate lab step.
CircRNA Synthesis Market- Geographical Insights
Asia Pacific has built a strong translational ecosystem around CircRNA, with China bringing together academic research, biotechnology advancement, and regulatory oversight. In January 2025, Shanghai CirCode Biomed announced that its HM2002 circular RNA therapeutic had received Investigational New Drug approval from China's NMPA. The company described this as the CircRNA therapeutic to receive such approval in China. The impact of this milestone goes beyond the HM2002 therapy itself. It signals a growing need for manufacturing, tight control over impurities, detailed analytical characterization, and scalable circularization techniques. China continues to advance synthesis research, including work in 2025 on scarless circularization and self-splicing systems. This region is not merely a consumer of CircRNA research; it is actively shaping the technology through both translational ambitions and innovation. The synergy between development and science makes Asia Pacific a key driver in the field.
North America's involvement in CircRNA is heavily influenced by the interplay among RNA technology providers, therapeutic developers, and U.S. regulatory processes. On May 30, 2025, CirCode announced that HM2002 had received FDA IND clearance for heart disease, expanding the therapy's regulatory journey beyond China. In another development, the FDA's orphan-designation database shows that a circular RNA therapy expressing hepatocyte growth factor was granted orphan designation on October 23, 2025, for thromboangiitis obliterans. These regulatory steps emphasize the need for quality therapeutic-grade synthesis and rigorous documentation. Key areas include identity verification, purity assessment, consistent production, and robust manufacturing controls. North America's role is central in moving CircRNA from lab-scale experiments to developed therapeutic programs. The market is shifting toward formalized production standards and analytical rigor, marking a transition from research-grade to development-ready CircRNA.
CircRNA Synthesis Market- Competitive Landscape:
Competition is now distinguished by the ability to manage the CircRNA workflow instead of just providing RNA reagents. GenScript combines custom synthesis with several circularization methods and purification, while GENEWIZ from Azenta pushes a unique group I-intron workflow for high-quality circular RNA production. Creative Biolabs also integrates sequence design, circularization, purification, and validation that focuses on CircRNA applications. Technology developers compete by enhancing cellular performance and improving therapeutic outcomes. Circio states that in its 2025 report, the new circVec 4.0 platform boosted protein output by 50 percent over the earlier circVec 3.2 version. What this means for competition is a move toward process power designed for specific uses and clear performance metrics rather than merely the ability to make CircRNA.
Recent Developments:
In March 2025, researchers created a multi-step purification process that used enzymes and cellulose-based methods to remove the main immunogenic CircRNA by-products. After refining the process, they observed more than a ten-fold improvement in CircRNA production yield.
In July 2025, scientists introduced a chemical circularization technique for RNA made through in vitro transcription. This method was designed to expand the types of structures that can be built using chemical synthesis. It successfully produced chem-CircRNAs ranging from 35 to 4,000 nucleotides in length, achieving circularization efficiency as high as 60 percent.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CIRCRNA SYNTHESIS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- GenScript
- LGC Biosearch Technologies
- Creative Biogene
- SBS Genetech
- Applied Biological Materials Inc.
- Amerigo Scientific
- BOC Sciences
- GeneCopoeia, Inc.
- Guangzhou Geneseed Biotech. Co., Ltd.
- Creative Biolabs
- Thermo Fisher Scientific
- Azenta / GENEWIZ
- VectorBuilder
- Twist Bioscience
- TriLink BioTechnologies
- Others
GLOBAL CIRCRNA SYNTHESIS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Instruments
- Reagents & Kits
- Services
GLOBAL CIRCRNA SYNTHESIS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Drug Discovery
- Therapeutics Development
- Others
GLOBAL CIRCRNA SYNTHESIS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
GLOBAL CIRCRNA SYNTHESIS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. CircRNA Synthesis Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. CircRNA Synthesis Market Snippet by Product Type
- 2.1.2. CircRNA Synthesis Market Snippet by Application
- 2.1.3. CircRNA Synthesis Market Snippet by End User
- 2.1.4. CircRNA Synthesis Market Snippet by Country
- 2.1.5. CircRNA Synthesis Market Snippet by Region
- 2.2. Competitive Insights
3. CircRNA Synthesis Key Market Trends
- 3.1. CircRNA Synthesis Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. CircRNA Synthesis Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. CircRNA Synthesis Market Opportunities
- 3.4. CircRNA Synthesis Market Future Trends
4. CircRNA Synthesis Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. CircRNA Synthesis Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. CircRNA Synthesis Market Landscape
- 6.1. CircRNA Synthesis Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. CircRNA Synthesis Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
- 7.1.2. Instruments
- 7.1.3. Reagents & Kits
- 7.1.4. Services
8. CircRNA Synthesis Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 8.1.2. Drug Discovery
- 8.1.3. Therapeutics Development
- 8.1.4. Others
9. CircRNA Synthesis Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
- 9.1.2. Academic & Research Institutes
- 9.1.3. Pharmaceutical & Biotechnology Companies
- 9.1.4. Others
10. CircRNA Synthesis Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. CircRNA Synthesis Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. CircRNA Synthesis Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.8. UK
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.9. France
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.10. Italy
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.11. Spain
- 10.3.11.1. Overview
- 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.12. The Netherlands
- 10.3.12.1. Overview
- 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Overview
- 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.14. Russia
- 10.3.14.1. Overview
- 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.15. Poland
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.16. Denmark
- 10.3.16.1. Overview
- 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.3.17. Rest of Europe
- 10.3.17.1. Overview
- 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. CircRNA Synthesis Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.7. China
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.8. India
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.12. Indonesia
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.13. Thailand
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.15. Taiwan
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.16. Vietnam
- 10.4.16.1. Overview
- 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.4.17. Rest of APAC
- 10.4.17.1. Overview
- 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. CircRNA Synthesis Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. CircRNA Synthesis Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.8. UAE
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.13. Iran
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.14. Qatar
- 10.6.14.1. Overview
- 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 10.6.15. Rest of MEA
- 10.6.15.1. Overview
- 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
- 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- CircRNA Synthesis Industry
- 11.1. Competitive Benchmarking
- 11.1.1. Competitive Dashboard
- 11.1.2. Competitive Positioning
- 11.2. Company Profiles
- 11.2.1. GenScript
- 11.2.2. LGC Biosearch Technologies
- 11.2.3. Creative Biogene
- 11.2.4. SBS Genetech
- 11.2.5. Applied Biological Materials Inc.
- 11.2.6. Amerigo Scientific
- 11.2.7. BOC Sciences
- 11.2.8. GeneCopoeia, Inc.
- 11.2.9. Guangzhou Geneseed Biotech. Co., Ltd.
- 11.2.10. Creative Biolabs
- 11.2.11. Thermo Fisher Scientific
- 11.2.12. Azenta / GENEWIZ
- 11.2.13. VectorBuilder
- 11.2.14. Twist Bioscience
- 11.2.15. TriLink BioTechnologies
- 11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
